Latvia Pyruvate Kinase Market (2025-2031) | Growth, Companies, Value, Forecast, Trends, Industry, Analysis, Size & Revenue, Outlook, Competitive Landscape, Share, Segmentation

Market Forecast By Drugs (Pyrukynd (Mitapivat), RPL301) And Competitive Landscape
Product Code: ETC7919949 Publication Date: Sep 2024 Updated Date: Nov 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Latvia Pyruvate Kinase Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Latvia`s import shipments of pyruvate kinase in 2024 continued to see a high concentration from top exporting countries such as Denmark, Lithuania, Germany, Italy, and Poland. The Herfindahl-Hirschman Index (HHI) indicated a significant increase in market concentration from 2023 to 2024. With a compound annual growth rate (CAGR) of 18.29% from 2020 to 2024, the market for pyruvate kinase imports in Latvia has shown strong expansion. The growth rate from 2023 to 2024 at 8.28% further highlights the increasing demand and competitiveness in this sector.

Latvia Pyruvate Kinase Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

  • Latvia Pyruvate Kinase Market Outlook
  • Market Size of Latvia Pyruvate Kinase Market, 2024
  • Forecast of Latvia Pyruvate Kinase Market, 2031
  • Historical Data and Forecast of Latvia Pyruvate Kinase Revenues & Volume for the Period 2021- 2031
  • Latvia Pyruvate Kinase Market Trend Evolution
  • Latvia Pyruvate Kinase Market Drivers and Challenges
  • Latvia Pyruvate Kinase Price Trends
  • Latvia Pyruvate Kinase Porter's Five Forces
  • Latvia Pyruvate Kinase Industry Life Cycle
  • Historical Data and Forecast of Latvia Pyruvate Kinase Market Revenues & Volume By Drugs for the Period 2021- 2031
  • Historical Data and Forecast of Latvia Pyruvate Kinase Market Revenues & Volume By Pyrukynd (Mitapivat) for the Period 2021- 2031
  • Historical Data and Forecast of Latvia Pyruvate Kinase Market Revenues & Volume By RPL301 for the Period 2021- 2031
  • Latvia Pyruvate Kinase Import Export Trade Statistics
  • Market Opportunity Assessment By Drugs
  • Latvia Pyruvate Kinase Top Companies Market Share
  • Latvia Pyruvate Kinase Competitive Benchmarking By Technical and Operational Parameters
  • Latvia Pyruvate Kinase Company Profiles
  • Latvia Pyruvate Kinase Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Latvia Pyruvate Kinase Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Latvia Pyruvate Kinase Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Latvia Pyruvate Kinase Market Overview

3.1 Latvia Country Macro Economic Indicators

3.2 Latvia Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F

3.3 Latvia Pyruvate Kinase Market - Industry Life Cycle

3.4 Latvia Pyruvate Kinase Market - Porter's Five Forces

3.5 Latvia Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F

4 Latvia Pyruvate Kinase Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of pyruvate kinase deficiency in Latvia

4.2.2 Growing awareness about the benefits of early diagnosis and treatment of pyruvate kinase disorders

4.2.3 Advancements in medical research leading to improved treatment options for pyruvate kinase deficiency

4.3 Market Restraints

4.3.1 Limited availability of specialized healthcare services for pyruvate kinase disorders in Latvia

4.3.2 High costs associated with diagnosis and treatment of pyruvate kinase deficiency

4.3.3 Lack of reimbursement policies for pyruvate kinase disorder treatments

5 Latvia Pyruvate Kinase Market Trends

6 Latvia Pyruvate Kinase Market, By Types

6.1 Latvia Pyruvate Kinase Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 Latvia Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F

6.1.3 Latvia Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F

6.1.4 Latvia Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F

7 Latvia Pyruvate Kinase Market Import-Export Trade Statistics

7.1 Latvia Pyruvate Kinase Market Export to Major Countries

7.2 Latvia Pyruvate Kinase Market Imports from Major Countries

8 Latvia Pyruvate Kinase Market Key Performance Indicators

8.1 Number of patients diagnosed with pyruvate kinase deficiency annually in Latvia

8.2 Adoption rate of new diagnostic technologies for pyruvate kinase disorders

8.3 Rate of participation in pyruvate kinase deficiency awareness campaigns

9 Latvia Pyruvate Kinase Market - Opportunity Assessment

9.1 Latvia Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F

10 Latvia Pyruvate Kinase Market - Competitive Landscape

10.1 Latvia Pyruvate Kinase Market Revenue Share, By Companies, 2024

10.2 Latvia Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All